82 FR 49816 - Agency Information Collection Activities: Proposed Collection; Comment Request

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services

Federal Register Volume 82, Issue 207 (October 27, 2017)

The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (the PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.

[Federal Register Volume 82, Number 207 (Friday, October 27, 2017)]
[Notices]
[Pages 49816-49817]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-23451]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[Document Identifier: CMS-10518 and CMS-10549]


Agency Information Collection Activities: Proposed Collection; 
Comment Request

AGENCY: Centers for Medicare & Medicaid Services, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is 
announcing an opportunity for the public to comment on CMS' intention 
to collect information from the public. Under the Paperwork Reduction 
Act of 1995 (the PRA), federal agencies are required to publish notice 
in the Federal Register concerning each proposed collection of 
information (including each proposed extension or reinstatement of an 
existing collection of information) and to allow 60 days for public 
comment on the proposed action. Interested persons are invited to send 
comments regarding our burden estimates or any other aspect of this 
collection of information, including the necessity and utility of the 
proposed information collection for the proper performance of the 
agency's functions, the accuracy of the estimated burden, ways to 
enhance the quality, utility, and clarity of the information to be 
collected, and the use of automated collection techniques or other 
forms of information technology to minimize the information collection 
burden.

DATES: Comments must be received by December 26, 2017.

ADDRESSES: When commenting, please reference the document identifier or 
OMB control number. To be assured consideration, comments and 
recommendations must be submitted in any one of the following ways:
    1. Electronically. You may send your comments electronically to 
http://www.regulations.gov. Follow the instructions for ``Comment or 
Submission'' or ``More Search Options'' to find the information 
collection document(s) that are accepting comments.
    2. By regular mail. You may mail written comments to the following 
address: CMS, Office of Strategic Operations and Regulatory Affairs, 
Division of Regulations Development, Attention: Document Identifier/OMB 
Control Number ___, Room C4-26-05, 7500 Security Boulevard, Baltimore, 
Maryland 21244-1850.
    To obtain copies of a supporting statement and any related forms 
for the proposed collection(s) summarized in this notice, you may make 
your request using one of following:
    1. Access CMS' Web site address at http://www.cms.hhs.gov/PaperworkReductionActof1995.
    2. Email your request, including your address, phone number, OMB 
number, and CMS document identifier, to [email protected].
    3. Call the Reports Clearance Office at (410) 786-1326.

FOR FURTHER INFORMATION CONTACT: William Parham at (410) 786-4669.

SUPPLEMENTARY INFORMATION:

Contents

    This notice sets out a summary of the use and burden associated 
with the following information collections. More detailed information 
can be found in each collection's supporting statement and associated 
materials (see ADDRESSES).
CMS-10518 Application for Participation in the Intravenous Immune 
Globulin (IVIG) Demonstration
CMS-10549 Generic Clearance for Questionnaire Testing and 
Methodological Research for the Medicare Current Beneficiary Survey 
(MCBS)
    Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain 
approval from the Office of Management and Budget (OMB) for each 
collection of information they conduct or sponsor. The term 
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 
1320.3(c) and includes agency requests or requirements that members of 
the public submit reports, keep records, or provide information to a 
third party. Section 3506(c)(2)(A) of the PRA requires federal agencies 
to publish a 60-day notice in the Federal Register

[[Page 49817]]

concerning each proposed collection of information, including each 
proposed extension or reinstatement of an existing collection of 
information, before submitting the collection to OMB for approval. To 
comply with this requirement, CMS is publishing this notice.

Information Collection

    1. Type of Information Collection Request: Extension of a currently 
approved collection; Title of Information Collection: Application for 
Participation in the Intravenous Immune Globulin (IVIG) Demonstration; 
Use: Traditional fee-for-service (FFS) Medicare covers some or all 
components of home infusion services depending on the circumstances. By 
special statutory provision, Medicare Part B covers intravenous immune 
globulin (IVIG) for persons with primary immune deficiency disease 
(PIDD) who wish to receive the drug at home. However, Medicare does not 
separately pay for any services or supplies to administer it if the 
person is not homebound and otherwise receiving services under a 
Medicare Home Health episode of care. As a result, many beneficiaries 
have chosen to receive the drug at their doctor's office or in an 
outpatient hospital setting.
    On September 29, 2017, the ``Disaster Tax Relief and Airport and 
Airway Extension Act of 2017'' was enacted into law. Section 302 of 
this legislation extends the Medicare IVIG Demonstration through 
December 31, 2020. While existing beneficiaries enrolled in the 
demonstration as of September 30, 2017 will be automatically re-
enrolled, in order to continue to enroll new beneficiaries into the 
demonstration, an application is required. The original enrollment and 
financial limits remain and CMS will continue to monitor both to assure 
that statutory limitations are not exceeded.
    This collection of information is for the application to 
participate in the demonstration. Participation is voluntary and may be 
terminated by the beneficiary at any time. Beneficiaries who do not 
participate will continue to be eligible to receive all of the regular 
Medicare Part B benefits that they are would be eligible for in the 
absence of the demonstration. Form Number: CMS-10518 (OMB control 
number: 0938-1246); Frequency: Annually; Affected Public: Individuals 
and households; Number of Respondents: 1,220; Total Annual Responses: 
1,220 Total Annual Hours: 305. (For policy questions regarding this 
collection contact Jody Blatt at 410-786-6921.)
    2. Type of Information Collection Request: Extension without change 
of a currently approved collection; Title of Information Collection: 
Generic Clearance for Questionnaire Testing and Methodological Research 
for the Medicare Current Beneficiary Survey (MCBS); Use: The purpose of 
this OMB clearance package is to extend the approval of the generic 
clearance to support an effort to evaluate the operations and content 
of the Medicare Current Beneficiary Survey (MCBS). The MCBS is a 
continuous, multipurpose survey of a nationally representative sample 
of aged, disabled, and institutionalized Medicare beneficiaries. The 
MCBS, which is sponsored by the Centers for Medicare & Medicaid 
Services (CMS), is the only comprehensive source of information on the 
health status, health care use and expenditures, health insurance 
coverage, and socioeconomic and demographic characteristics of the 
entire spectrum of Medicare beneficiaries. The core of the MCBS is a 
series of interviews with a stratified random sample of the Medicare 
population, including aged and disabled enrollees, residing in the 
community or in institutions. Questions are asked about enrollees' 
patterns of health care use, charges, insurance coverage, and payments 
over time. Respondents are asked about their sources of health care 
coverage and payment, their demographic characteristics, their health 
and work history, and their family living circumstances. In addition to 
collecting information through the core questionnaire, the MCBS 
collects information on special topics. Form Number: CMS-10549 (OMB 
control number 0938-1275); Frequency: Occasionally; Affected Public: 
Individuals or Households; Number of Respondents: 1,500; Total Annual 
Responses: 1,500; Total Annual Hours: 1,117. (For policy questions 
regarding this collection contact William Long at 410-786-7927.)

    Dated: October 24, 2017.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and 
Regulatory Affairs.
[FR Doc. 2017-23451 Filed 10-26-17; 8:45 am]
 BILLING CODE 4120-01-P